![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
G01N 33/563 | |||
C12N 15/00 | |||
A61K 39/395 | |||
C12P 21/00 | |||
A61P 35/00 |
(11) | Number of the document | 1417232 |
(13) | Kind of document | T |
(96) | European patent application number | 02744320.9 |
Date of filing the European patent application | 2002-06-13 | |
(97) | Date of publication of the European application | 2004-05-12 |
(45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2002/018748 |
Date | 2002-06-13 |
(87) | Number | WO 2002/100348 |
Date | 2002-12-19 |
(30) | Number | Date | Country code |
298172 | 2001-06-13 | US |
(72) |
VAN DE WINKEL, Jan, NL
VAN DIJK, Marcus A., NL
GERRITSEN, Arnout F., NL
HALK, Edward, US
|
(73) |
Genmab A/S,
Bredgade 34 E, 1260 Copenhagen K,
DK
|
(54) | HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) |
HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) |